3-57446258-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001366028.2(DNAH12):c.3952C>T(p.Leu1318Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.517 in 1,550,246 control chromosomes in the GnomAD database, including 212,370 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.45 ( 17154 hom., cov: 32)
Exomes 𝑓: 0.52 ( 195216 hom. )
Consequence
DNAH12
NM_001366028.2 synonymous
NM_001366028.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.16
Genes affected
DNAH12 (HGNC:2943): (dynein axonemal heavy chain 12) Predicted to enable several functions, including ATP binding activity; dynein intermediate chain binding activity; and dynein light intermediate chain binding activity. Predicted to be involved in microtubule-based movement. Predicted to be located in cilium; cytoplasm; and microtubule. Predicted to be part of dynein complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 3-57446258-G-A is Benign according to our data. Variant chr3-57446258-G-A is described in ClinVar as [Benign]. Clinvar id is 402638.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.16 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.577 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH12 | NM_001366028.2 | c.3952C>T | p.Leu1318Leu | synonymous_variant | 27/74 | ENST00000495027.6 | NP_001352957.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH12 | ENST00000495027.6 | c.3952C>T | p.Leu1318Leu | synonymous_variant | 27/74 | 5 | NM_001366028.2 | ENSP00000418137.2 | ||
DNAH12 | ENST00000351747.6 | c.3883C>T | p.Leu1295Leu | synonymous_variant | 27/59 | 5 | ENSP00000295937.3 |
Frequencies
GnomAD3 genomes AF: 0.450 AC: 68385AN: 151868Hom.: 17155 Cov.: 32
GnomAD3 genomes
AF:
AC:
68385
AN:
151868
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.525 AC: 82766AN: 157752Hom.: 22588 AF XY: 0.534 AC XY: 44459AN XY: 83258
GnomAD3 exomes
AF:
AC:
82766
AN:
157752
Hom.:
AF XY:
AC XY:
44459
AN XY:
83258
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.524 AC: 733151AN: 1398260Hom.: 195216 Cov.: 39 AF XY: 0.528 AC XY: 364059AN XY: 689638
GnomAD4 exome
AF:
AC:
733151
AN:
1398260
Hom.:
Cov.:
39
AF XY:
AC XY:
364059
AN XY:
689638
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.450 AC: 68390AN: 151986Hom.: 17154 Cov.: 32 AF XY: 0.458 AC XY: 33999AN XY: 74308
GnomAD4 genome
AF:
AC:
68390
AN:
151986
Hom.:
Cov.:
32
AF XY:
AC XY:
33999
AN XY:
74308
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1835
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at